Skip to Content
Clinics and PracticeClinics and Practice
  • Case Report
  • Open Access

3 May 2011

3 Pages

Neuroradiological Findings of an Adolescent with Early Treated Phenylketonuria: Is Phenylalanine Restriction Enough?

,
,
,
,
,
and
1
Department of Biology, Medicine and Social Sciences, Universidade do Sul de Santa Catarina (UNISUL), Av. José Acácio Moreira, Dehon. Tubarão, Santa Catarina 88704-900, Brazil
2
Department of Radiology, Hospital São João Batista, Santa Catarina, Brazil
3
Neurology Division, Department of Internal Medicine, Universidade Federal de Santa Catarina (UFSC), Santa Catarina, Brazil
4
Medical Genetics Center, National Health Institute (INSA), Porto, Portugal

Abstract

Phenylketonuria is caused by mutations in the enzyme phenylalanine hydroxylase gene, that can result in abnormal concentrations of phenylalanine on blood, resulting in metabolites that can cause brain damage. The treatment is based on dietary restriction of phenylalanine, and noncompliance with treatment may result in damage of the brain function. Brain abnormalities can be seen on magnetic resonance imaging of these individuals. Studies indicate that the appearance of abnormalities in white matter reflects high levels of phenylalanine on the blood. This case will show the clinical and neuroradiological aspects of a teenager with constant control of phenylalanine levels. Despite the continuous monitoring and early treatment, the magnetic resonance imaging identified impressive abnormalities in the white matter. This leads us to one question: is the restriction of phenylalanine sufficient to prevent changes in the white matter in patients with phenylketonuria?

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.